Dennis M. Lanfear, See Remarks at Coherus BioSciences, Inc. (CHRS), sold 41,968 shares at $16.26 ($682K) on 2018-05-16, disclosed to the SEC on 2018-05-17.
Open-market sale of $682k CHRS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.26 | 20,984 | $341K | 50.0% |
| 2 | $16.26 | 20,984 | $341K | 50.0% |
| Total | $16.26 avg | 41,968 | $682K | 100% |
| Filing → |
| CHRS | SELL | 2019-11-25 | $464K | — | Filing → |
| CHRS | SELL | 2019-11-22 | $14.8M | — | Filing → |
| CHRS | SELL | 2019-05-31 | $1.3M | — | Filing → |